These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21538450)

  • 21. Some challenges with statistical inference in adaptive designs.
    Hung HM; Wang SJ; Yang P
    J Biopharm Stat; 2014; 24(5):1059-72. PubMed ID: 24915027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential methods and group sequential designs for comparative clinical trials.
    Sébille V; Bellissant E
    Fundam Clin Pharmacol; 2003 Oct; 17(5):505-16. PubMed ID: 14703713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Designing clinical trials with (restricted) mean survival time endpoint: Practical considerations.
    Eaton A; Therneau T; Le-Rademacher J
    Clin Trials; 2020 Jun; 17(3):285-294. PubMed ID: 32063031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adaptive designs: The Swiss Army knife among clinical trial designs?
    Bretz F; Gallo P; Maurer W
    Clin Trials; 2017 Oct; 14(5):417-424. PubMed ID: 28982262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adaptive designs for sequential experiments.
    Lin ZY; Zhang LX
    J Zhejiang Univ Sci; 2003; 4(2):214-20. PubMed ID: 12659237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design of telehealth trials--introducing adaptive approaches.
    Law LM; Wason JM
    Int J Med Inform; 2014 Dec; 83(12):870-80. PubMed ID: 25293533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A simple and flexible graphical approach for adaptive group-sequential clinical trials.
    Sugitani T; Bretz F; Maurer W
    J Biopharm Stat; 2016; 26(2):202-16. PubMed ID: 25372071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Building efficient comparative effectiveness trials through adaptive designs, utility functions, and accrual rate optimization: finding the sweet spot.
    Gajewski BJ; Berry SM; Quintana M; Pasnoor M; Dimachkie M; Herbelin L; Barohn R
    Stat Med; 2015 Mar; 34(7):1134-49. PubMed ID: 25640114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Group sequential designs for three-arm 'gold standard' non-inferiority trials with fixed margin.
    Schlömer P; Brannath W
    Stat Med; 2013 Dec; 32(28):4875-89. PubMed ID: 23970488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient recruitment strategies for adaptive enrichment designs with time-to-event endpoints.
    Uozumi R; Yada S; Kawaguchi A
    BMC Med Res Methodol; 2019 Jul; 19(1):159. PubMed ID: 31331277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel Bayesian adaptive design incorporating both primary and secondary endpoints for randomized IIB chemoprevention study of women at increased risk for breast cancer.
    Gajewski BJ; Kimler BF; Koestler DC; Mudaranthakam DP; Young K; Fabian CJ
    Trials; 2022 Dec; 23(1):981. PubMed ID: 36471449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An adaptive two-arm clinical trial using early endpoints to inform decision making: design for a study of sub-acromial spacers for repair of rotator cuff tendon tears.
    Parsons N; Stallard N; Parsons H; Wells P; Underwood M; Mason J; Metcalfe A
    Trials; 2019 Dec; 20(1):694. PubMed ID: 31815651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of benefit.
    Royston P; Barthel FM; Parmar MK; Choodari-Oskooei B; Isham V
    Trials; 2011 Mar; 12():81. PubMed ID: 21418571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benefits, challenges and obstacles of adaptive clinical trial designs.
    Chow SC; Corey R
    Orphanet J Rare Dis; 2011 Nov; 6():79. PubMed ID: 22129361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Group sequential and adaptive designs: a novel, promising tool for nursing research.
    Baldi I; Gouchon SM; Di Giulio P; Buja A; Gregori D
    J Adv Nurs; 2011 Aug; 67(8):1824-33. PubMed ID: 21517937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Review of Clinical Trials With an Adaptive Design and Health Economic Analysis.
    Flight L; Arshad F; Barnsley R; Patel K; Julious S; Brennan A; Todd S
    Value Health; 2019 Apr; 22(4):391-398. PubMed ID: 30975389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview, hurdles, and future work in adaptive designs: perspectives from a National Institutes of Health-funded workshop.
    Coffey CS; Levin B; Clark C; Timmerman C; Wittes J; Gilbert P; Harris S
    Clin Trials; 2012 Dec; 9(6):671-80. PubMed ID: 23250942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urn models for response-adaptive randomized designs: a simulation study based on a non-adaptive randomized trial.
    Ghiglietti A; Scarale MG; Miceli R; Ieva F; Mariani L; Gavazzi C; Paganoni AM; Edefonti V
    J Biopharm Stat; 2018; 28(6):1203-1215. PubMed ID: 29565749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. When to keep it simple - adaptive designs are not always useful.
    Wason JMS; Brocklehurst P; Yap C
    BMC Med; 2019 Aug; 17(1):152. PubMed ID: 31370839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation by simulation of clinical trial designs for evaluation of treatment during a viral haemorrhagic fever outbreak.
    Manchon P; Belhadi D; Mentré F; Laouénan C
    BMC Med Res Methodol; 2021 May; 21(1):98. PubMed ID: 33952195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.